These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32718901)

  • 21. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
    Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
    Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late gadolinium enhancement cardiac magnetic resonance imaging in prognostic assessment of hypertrophic cardiomyopathy.
    Bouabdallaoui N; Ennezat PV; Durand E; Puymirat E; Macron L
    Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):1024. PubMed ID: 23644935
    [No Abstract]   [Full Text] [Related]  

  • 24. Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy.
    Raiker N; Vullaganti S; Collins JD; Allen BD; Choudhury L
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1147-1156. PubMed ID: 32166506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac Magnetic Resonance Imaging Features in Hypertrophic Cardiomyopathy Diagnosed at <21 Years of Age.
    Bonura ED; Bos JM; Abdelsalam MA; Araoz PA; Ommen SR; Ackerman MJ; Geske JB
    Am J Cardiol; 2020 Apr; 125(8):1249-1255. PubMed ID: 32088002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.
    Green JJ; Berger JS; Kramer CM; Salerno M
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):370-7. PubMed ID: 22498326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrepancy Between Pathological Progression and Clinical Stability in a Young Patient With Hypertrophic Cardiomyopathy.
    Raman B; Wen D; Chan K; Watkins H; Neubauer S; Mahmod M
    Circ Cardiovasc Imaging; 2018 Nov; 11(11):e008154. PubMed ID: 30571321
    [No Abstract]   [Full Text] [Related]  

  • 28. Spiral hypertrophic cardiomyopathy as detected by cardiac magnetic resonance.
    Amin N; Williams RB; Yarmozik JA; Biederman RW
    Echocardiography; 2014 Mar; 31(3):E88-91. PubMed ID: 24749165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy.
    Spinner JA; Noel CV; Denfield SW; Krishnamurthy R; Jeewa A; Dreyer WJ; Maskatia SA
    Am J Cardiol; 2016 Apr; 117(8):1342-8. PubMed ID: 26892450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late gadolinium enhancement on cardiac magnetic resonance represents the depolarizing and repolarizing electrically damaged foci causing malignant ventricular arrhythmia in hypertrophic cardiomyopathy.
    Sakamoto N; Kawamura Y; Sato N; Nimura A; Matsuki M; Yamauchi A; Kanno T; Tanabe Y; Takeuchi T; Natori S; Saijo Y; Aburano T; Hasebe N
    Heart Rhythm; 2015 Jun; 12(6):1276-84. PubMed ID: 25684235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
    J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular Hinge Point Fibrosis as a Pathological Marker of Hypertrophic Cardiomyopathy in the Absence of Significant Left Ventricular Hypertrophy?
    Ding WY; Cooper RM; Hasleton J; McKay V; Modi S
    Can J Cardiol; 2016 Dec; 32(12):1577.e13-1577.e14. PubMed ID: 27177834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy.
    Rodriguez-Granillo GA; Deviggiano A; Capunay C; Zan MC; Carrascosa P
    Arq Bras Cardiol; 2016 Jul; 107(1):48-54. PubMed ID: 27305110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.
    Chan RH; Maron BJ; Olivotto I; Assenza GE; Haas TS; Lesser JR; Gruner C; Crean AM; Rakowski H; Rowin E; Udelson J; Lombardi M; Tomberli B; Spirito P; Formisano F; Marra MP; Biagini E; Autore C; Manning WJ; Appelbaum E; Roberts WC; Basso C; Maron MS
    Am J Cardiol; 2015 Aug; 116(3):436-41. PubMed ID: 26026863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of apical subtype of hypertrophic cardiomyopathy using cardiac magnetic resonance imaging with gadolinium enhancement.
    Kebed KY; Al Adham RI; Bishu K; Askew JW; Klarich KW; Araoz PA; Foley TA; Glockner JF; Nishimura RA; Anavekar NS
    Am J Cardiol; 2014 Sep; 114(5):777-82. PubMed ID: 25037678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LGE and the risk of sudden death in HCM.
    Alla VM; Koneru S; Hunter C; Mooss A
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):761-2; author reply 762-3. PubMed ID: 22789948
    [No Abstract]   [Full Text] [Related]  

  • 38. Histogram Analysis of Native T
    Wu CW; Wu R; Shi RY; An DA; Chen BH; Jiang M; Bacyinski A; Rahim A; Deen JM; Hu J; Han TT; Xu JR; Wu LM
    J Magn Reson Imaging; 2019 Mar; 49(3):668-677. PubMed ID: 30142234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis.
    Scott PA; Rosengarten JA; Curzen NP; Morgan JM
    Eur J Heart Fail; 2013 Sep; 15(9):1019-27. PubMed ID: 23558217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the potentially arrhythmogenic substrate in the acute phase of ST-segment elevation myocardial infarction.
    Penela D; Acosta J; Andreu D; Ortiz-Perez JT; Bosch X; Perea RJ; de Caralt TM; Fernández-Armenta J; Soto-Iglesias D; Prat-Gonzalez S; Borràs R; Mont L; Hervas V; Morales-Ruiz M; Jiménez W; Mira A; Donnelly J; Ekinci O; Lasalvia L; Berruezo A
    Heart Rhythm; 2017 Apr; 14(4):592-598. PubMed ID: 28104481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.